Search research articles
Contact Us
Filters
Showing results (21-30 of 99) with videos related to
Page
of 10
Sort By:
International Journal of Cancer
|
November 2, 2007
Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells
Zafira Castaño, Nuria Vergara-Irigaray, Maria J Pajares, et al.
Iscience
|
June 22, 2026
Type 2 and type 1 diabetes have opposing effects on the systemic murine complement alternative pathway
Lucie Colineau, Olga Kolodziej, Daniel Ajona, et al.
The Lancet. Oncology
|
March 31, 2007
Alternative splicing: an emerging topic in molecular and clinical oncology
María J Pajares, Teresa Ezponda, Raúl Catena, et al.
Frontiers in Immunology
|
March 3, 2020
Editorial: The Role of Complement in Tumors
Barbara E Rolfe, Ruben Pio, Trent M Woodruff, et al.
Cancer Research
|
December 28, 2013
Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer
Fernando J de Miguel, Ravi D Sharma, María J Pajares, et al.
BMC Genomics
|
June 19, 2016
EventPointer: an effective identification of alternative splicing events using junction arrays
Juan P Romero, Ander Muniategui, Fernando J De Miguel, et al.
Molecular Cancer
|
June 10, 2010
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
Yi-Fan Hsu, Daniel Ajona, Leticia Corrales, et al.
Human Mutation
|
April 5, 2008
Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines
Pedro P Medina, Octavio A Romero, Takashi Kohno, et al.
EMBO Molecular Medicine
|
February 7, 2014
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
Marta Larrayoz, Ruben Pio, María J Pajares, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
December 13, 2012
Multiscale in situ analysis of the role of dyskerin in lung cancer cells
Ignacio Fernandez-Garcia, Tamara Marcos, Arrate Muñoz-Barrutia, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 99) with videos related to
Sort By:
Page
of 10
International Journal of Cancer
|
November 2, 2007
Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells
Zafira Castaño, Nuria Vergara-Irigaray, Maria J Pajares, et al.
Iscience
|
June 22, 2026
Type 2 and type 1 diabetes have opposing effects on the systemic murine complement alternative pathway
Lucie Colineau, Olga Kolodziej, Daniel Ajona, et al.
The Lancet. Oncology
|
March 31, 2007
Alternative splicing: an emerging topic in molecular and clinical oncology
María J Pajares, Teresa Ezponda, Raúl Catena, et al.
Frontiers in Immunology
|
March 3, 2020
Editorial: The Role of Complement in Tumors
Barbara E Rolfe, Ruben Pio, Trent M Woodruff, et al.
Cancer Research
|
December 28, 2013
Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer
Fernando J de Miguel, Ravi D Sharma, María J Pajares, et al.
BMC Genomics
|
June 19, 2016
EventPointer: an effective identification of alternative splicing events using junction arrays
Juan P Romero, Ander Muniategui, Fernando J De Miguel, et al.
Molecular Cancer
|
June 10, 2010
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
Yi-Fan Hsu, Daniel Ajona, Leticia Corrales, et al.
Human Mutation
|
April 5, 2008
Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines
Pedro P Medina, Octavio A Romero, Takashi Kohno, et al.
EMBO Molecular Medicine
|
February 7, 2014
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
Marta Larrayoz, Ruben Pio, María J Pajares, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
December 13, 2012
Multiscale in situ analysis of the role of dyskerin in lung cancer cells
Ignacio Fernandez-Garcia, Tamara Marcos, Arrate Muñoz-Barrutia, et al.
Page
of 10